Imaging of compensatory mechanisms in Parkinson's disease

被引:70
作者
Appel-Cresswell, Silke [1 ,2 ]
de la Fuente-Fernandez, Raul [1 ,2 ]
Galley, Shawna [1 ]
McKeown, Martin J. [1 ,2 ]
机构
[1] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V6T 2B5, Canada
[2] Univ British Columbia, Dept Med Neurol, Vancouver, BC V6T 2B5, Canada
关键词
compensation; connectivity; functional MRI; imaging; Parkinson's disease; PET; POSITRON-EMISSION-TOMOGRAPHY; METABOLIC NETWORK ACTIVITY; IN-VIVO; L-DOPA; C-11; RACLOPRIDE; CONNECTIVITY; MOVEMENTS; BINDING; PET; DYSFUNCTION;
D O I
10.1097/WCO.0b013e32833b6019
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review The on-going quest for potentially disease-modifying therapies in Parkinson's disease has prompted the development of methods that can differentiate direct disease effects from compensatory processes. Recent findings PET studies have suggested a number of changes at the synaptic level to maintain integrity of dopaminergic systems. Functional MRI studies support the long-held belief that relatively intact cerebellar circuits may compensate for impaired basal ganglia function. Altered connectivity and increased spatial extent of activation also appear to be mechanisms through which motor and cognitive performance can be maintained. Summary Ascertaining which changes in brain activation in Parkinson's disease are, in fact, compensatory represents a serious challenge. Compensatory mechanisms have been demonstrated from the microscopic, synaptic level to the macroscopic, system level. Augmentation of compensatory mechanisms, in addition to ameliorating the loss of dopaminergic neurons, may represent a joint strategy for overall minimization of disability.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 52 条
  • [1] [C-11] RACLOPRIDE AND POSITRON EMISSION TOMOGRAPHY IN PREVIOUSLY UNTREATED PATIENTS WITH PARKINSONS-DISEASE - INFLUENCE OF L-DOPA AND LISURIDE THERAPY ON STRIATAL DOPAMINE D-2-RECEPTORS
    ANTONINI, A
    SCHWARZ, J
    OERTEL, WH
    BEER, HF
    MADEJA, UD
    LEENDERS, KL
    [J]. NEUROLOGY, 1994, 44 (07) : 1325 - 1329
  • [2] Network modulation in the treatment of Parkinson's disease
    Asanuma, Kotaro
    Tang, Chengke
    Ma, Yilong
    Dhawan, Vijay
    Mattis, Paul
    Edwards, Christine
    Kaplitt, Michael G.
    Feigin, Andrew
    Eidelberg, David
    [J]. BRAIN, 2006, 129 : 2667 - 2678
  • [3] Elevated serotonin transporter binding in depressed patients with Parkinson's disease:: A preliminary PET study with [11C]DASB
    Boileau, Isabelle
    Warsh, Jerry J.
    Guttman, Mark
    Saint-Cyr, Jean A.
    McCluskey, Tina
    Rusjan, Pablo
    Houle, Sylvain
    Wilson, Alan A.
    Meyer, Jeffrey H.
    Kish, Stephen J.
    [J]. MOVEMENT DISORDERS, 2008, 23 (12) : 1776 - 1780
  • [4] Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-()-PHNO in drug-nave Parkinsons disease
    Boileau, Isabelle
    Guttman, Mark
    Rusjan, Pablo
    Adams, John R.
    Houle, Sylvain
    Tong, Junchao
    Hornykiewicz, Oleh
    Furukawa, Yoshiaki
    Wilson, Alan A.
    Kapur, Shitij
    Kish, Stephen J.
    [J]. BRAIN, 2009, 132 : 1366 - 1375
  • [5] Subcortical elevation of metabolism in Parkinson's disease - A critical reappraisal in the context of global mean normalization
    Borghammer, Per
    Cumming, Paul
    Aanerud, Joel
    Foerster, Stefan
    Gjedde, Albert
    [J]. NEUROIMAGE, 2009, 47 (04) : 1514 - 1521
  • [6] Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson's disease
    Borghammer, Per
    Cumming, Paul
    Aanerud, Joel
    Gjedde, Albert
    [J]. NEUROIMAGE, 2009, 45 (02) : 249 - 257
  • [7] A PET study of sequential finger movements of varying length in patients with Parkinson's disease
    Catalan, MJ
    Ishii, K
    Honda, M
    Samii, A
    Hallett, M
    [J]. BRAIN, 1999, 122 : 483 - 495
  • [8] Functional changes in the activity of cerebellum and frontostriatal regions during externally and internally timed movement in Parkinson's disease
    Cerasa, Antonio
    Hagberg, Gisela E.
    Peppe, Antonella
    Bianciardi, Marta
    Gioia, M. Cecilia
    Costa, Alberto
    Castriota-Scanderbeg, Alessandro
    Caltagirone, Carlo
    Sabatini, Umberto
    [J]. BRAIN RESEARCH BULLETIN, 2006, 71 (1-3) : 259 - 269
  • [9] The role of the striatum and hippocampus in planning - A PET activation study in Parkinson's disease
    Dagher, A
    Owen, AM
    Boecker, H
    Brooks, DJ
    [J]. BRAIN, 2001, 124 : 1020 - 1032
  • [10] Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease:: implications for dyskinesias
    de la Fuente-Fernández, R
    Sossi, V
    Huang, ZG
    Furtado, S
    Lu, JQ
    Calne, DB
    Ruth, TJ
    Stoessl, AJ
    [J]. BRAIN, 2004, 127 : 2747 - 2754